期刊文献+

甲状腺微小乳头状癌侧颈部淋巴结转移相关危险因素分析 被引量:12

Risk factors of lateral cervical metastasis in papillary thyroid microcarcinoma
下载PDF
导出
摘要 目的分析甲状腺微小乳头状癌侧颈部淋巴结转移相关危险因素,为更好的制定手术范围提供理论基础。方法回顾性分析2012年1月至2013年1月行甲状腺手术及侧颈部淋巴结清扫术,术后病理检查证实甲状腺癌微小乳头状癌患者120例。回顾分析患者侧颈部淋巴结转移、性别、年龄、肿瘤大小、中央区淋巴结转移等因素之间的关系。结果 120例患者总体转移率为73例(60.8%)。单因素分析显示,患者侧颈部淋巴结转移与肿瘤大小、肿瘤播散、腺体外侵犯、原发肿瘤位置及中央区淋巴结转移等有统计学差异,而与性别、年龄、是否存在沙砾体、癌灶数目及病灶单、双侧无统计学差异。多因素分析中,仅有肿瘤位置及中央区淋巴结转移与侧颈部淋巴结转移相关明显。结论甲状腺乳头状癌出现中央区或侧颈部淋巴结转移极为常见,在当原发肿瘤位于甲状腺中部或下极及中央区淋巴结转移时,在术前或术中,应仔细评估侧颈部淋巴结,如出现可疑淋巴结转移应积极行侧颈部淋巴结清扫术。 Objective To analysis the risk factors of lateral cervical node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC). Methods Clinical data of 120 patients with PTMC admitted and treated in Zhejiang Provincial Cancer Hospital from 2012 to 2013 were retrospectively reviewed. SPSS 21.0 was used to statistically analyze the clinical information and the risk factors of LNM. Results Among 120 patients, 73 patients (60.8%) presented LNM. Univariate analysis showed that tumor size, tumor spread, extrathyroidal invasion, primary tumor location and central compartment metastasis (CNM) were associated with LNM. Multivariate analysis showed that primary location and CNM were independent risk factors of LNM. Conclusion lymph node metastases are very common in PTMC, and the location of primary tumor and central compartment metastasis are the risk factors of lateral lymph node metastasis.
出处 《浙江医学》 CAS 2016年第11期787-790,共4页 Zhejiang Medical Journal
基金 浙江省卫生厅基金项目资助(2013KYB042 2014KYB038)
关键词 甲状腺微小乳头状癌 侧颈部淋巴结转移 中央区淋巴结转移 危险因素 Papillary thyroid micro-carcinoma Lateral lymph node metastasis Central compartment metastasis Risk factors
  • 相关文献

参考文献28

  • 1Kepenekci I, Demirkan A, Cakmak A, et al. Axillary lymph node metastasis as a late manifestation of papillary thyroid carcinoma [J]. Thyroid, 2009, 19(4): 417-419.
  • 2Davies L, Welch H G. Increasing incidence of thyroid cancer in the United States, 1973-2002[J]. Jama, 2006, 295(18): 2164-2167.
  • 3Mazeh H, Samet Y, Hochstein D, et al. Multifocality in well-differ- entiated thyroid carcinomas calls for total thyroidectomy [J]. Am J Surg, 2011,201(6): 770-775.
  • 4Hodgson N C, Button J, Solorzano C C. Thyroid cancer: is the in- cidence stillincreasing[J]?Ann Surg Oncol, 2004, 11(12): 1093-1097.
  • 5Shaha A R. Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis[J]. Surgery, 2004, 135(2): 237-239.
  • 6Davidson H C, Park B J, Johnson J T. Papillary thyroid cancer: controversies in the management of neck metastasis[J]. Laryngo- scope, 2008, 118(12): 2161-2165.
  • 7Roh J L, Kim J M, Park C I. Lateral cervical lymph node metas- tases from papillary thyroid carcinoma: pattern of nodal metas- tases and optimal strategy for neck dissection[J]. Ann Surg On- col, 2008, 15(4): 1177-1182.
  • 8Kupferman M E, Weinstock Y E, Santillan A A, et ai. Predictors of level V metastasis in well-differentiated thyroid cancer[J]. Head Neck, 2008, 30(11): 1469-1474.
  • 9Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malig- nancy for cervical lymph nodes in patients followed up for differ- entiated thyroid cancer[J]. J Clin Endocrinol Metab, 2007, 92(9): 3590-3594.
  • 10Som P M, Brandwein M, Lidov M, et al. The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings[J]. AJNR Am J Neuroradiol, 1994, 15(6): 1123-1128.

同被引文献77

引证文献12

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部